270 related articles for article (PubMed ID: 7657387)
21. Evaluation of NF2 gene deletion in sporadic schwannomas, meningiomas, and ependymomas by chromogenic in situ hybridization.
Begnami MD; Palau M; Rushing EJ; Santi M; Quezado M
Hum Pathol; 2007 Sep; 38(9):1345-50. PubMed ID: 17509660
[TBL] [Abstract][Full Text] [Related]
22. NF2 mutations in secretory and other rare variants of meningiomas.
Hartmann C; Sieberns J; Gehlhaar C; Simon M; Paulus W; von Deimling A
Brain Pathol; 2006 Jan; 16(1):15-9. PubMed ID: 16612978
[TBL] [Abstract][Full Text] [Related]
23. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
24. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel JA; Zhou JY; Rorke LB; Stenstrom C; Wainwright LM; Fogelgren B
Cancer Res; 1999 Jan; 59(1):74-9. PubMed ID: 9892189
[TBL] [Abstract][Full Text] [Related]
25. NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic mutations by denaturing HPLC and microarray-CGH.
Szijan I; Rochefort D; Bruder C; Surace E; Machiavelli G; Dalamon V; Cotignola J; Ferreiro V; Campero A; Basso A; Dumanski JP; Rouleau GA
Neuromolecular Med; 2003; 3(1):41-52. PubMed ID: 12665675
[TBL] [Abstract][Full Text] [Related]
26. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas.
Leone PE; Bello MJ; de Campos JM; Vaquero J; Sarasa JL; Pestaña A; Rey JA
Oncogene; 1999 Apr; 18(13):2231-9. PubMed ID: 10327069
[TBL] [Abstract][Full Text] [Related]
27. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
[TBL] [Abstract][Full Text] [Related]
28. INI1 mutations in meningiomas at a potential hotspot in exon 9.
Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A
Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377
[TBL] [Abstract][Full Text] [Related]
29. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
31. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults.
Raisanen J; Biegel JA; Hatanpaa KJ; Judkins A; White CL; Perry A
Brain Pathol; 2005 Jan; 15(1):23-8. PubMed ID: 15779233
[TBL] [Abstract][Full Text] [Related]
32. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
[TBL] [Abstract][Full Text] [Related]
33. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
[TBL] [Abstract][Full Text] [Related]
34. Infrequency of p53 gene mutations in ependymomas.
Fink KL; Rushing EJ; Schold SC; Nisen PD
J Neurooncol; 1996 Feb; 27(2):111-5. PubMed ID: 8699232
[TBL] [Abstract][Full Text] [Related]
35. Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosis.
Kotch C; Fisher MJ; Lin F; Zhong Y; Gallo D; Fan Z; Chen J; Santi M; Li MM
Cancer Genet; 2022 Apr; 262-263():1-4. PubMed ID: 34972035
[TBL] [Abstract][Full Text] [Related]
36. Low incidence of a nucleotide sequence alteration of the neurofibromatosis 2 gene in human breast cancers.
Yaegashi S; Sachse R; Ohuchi N; Mori S; Sekiya T
Jpn J Cancer Res; 1995 Oct; 86(10):929-33. PubMed ID: 7493911
[TBL] [Abstract][Full Text] [Related]
37. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
38. Inactivation patterns of NF2 and DAL-1/4.1B (EPB41L3) in sporadic meningioma.
Nunes F; Shen Y; Niida Y; Beauchamp R; Stemmer-Rachamimov AO; Ramesh V; Gusella J; MacCollin M
Cancer Genet Cytogenet; 2005 Oct; 162(2):135-9. PubMed ID: 16213361
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis 2 gene in human colorectal cancer.
Rustgi AK; Xu L; Pinney D; Sterner C; Beauchamp R; Schmidt S; Gusella JF; Ramesh V
Cancer Genet Cytogenet; 1995 Oct; 84(1):24-6. PubMed ID: 7497438
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization determination of 22q12-q13 deletion in two intracerebral ependymomas.
Rousseau-Merck M; Versteege I; Zattara-Cannoni H; Figarella D; Lena G; Aurias A; Vagner-Capodano AM
Cancer Genet Cytogenet; 2000 Sep; 121(2):223-7. PubMed ID: 11063814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]